Feb 5 (Reuters) - Kalytera Therapeutics Inc KALY.V :
* KALYTERA REPORTS ADDITIONAL POSITIVE DATA FOR CBD IN PREVENTION OF ACUTE GVHD
* KALYTERA THERAPEUTICS INC - ANTICIPATED THAT PHASE 2 STUDY WILL COMPLETE LATER THIS YEAR
* KALYTERA THERAPEUTICS INC - ANTICIPATED THAT WILL PROVIDE SUPPORT FOR PLANNED PHASE 3 STUDY THAT COMPANY EXPECTS TO INITIATE IN LATE-2019